Collaborative Attention Contrast Learning for Cancer Subtype Identification Based on Multi-Omics Data.

Area of Science:

• Bioinformatics
• Computational Biology
• Genomics

Background:

• Cancer subtype identification is crucial for understanding disease pathogenesis and developing personalized therapies.
• Multi-omics data integration is essential for accurate cancer subtyping, but high dimensionality and noise present challenges.
• Current methods struggle to optimally leverage discriminative information across diverse omics datasets.

Purpose of the Study:

• To propose a novel framework, Collaborative Attention Contrast Learning (CACL), for effective multi-omics data integration in cancer subtype classification.
• To enhance the extraction of discriminative features and improve clustering performance by maximizing relevant information and minimizing noise.
• To identify clinically significant cancer subgroups across diverse cancer types.

Main Methods:

• Developed the Collaborative Attention Contrast Learning (CACL) framework.
• Integrated a genetic attention module (GAM) for intra-omics feature capture.
• Incorporated an omics attention module (OAM) to refine inter-omics relationships.
• Utilized a contrastive loss function for optimizing feature extraction and enhancing discriminative ability.

Main Results:

• The CACL framework demonstrated superior performance compared to state-of-the-art methods in multi-omics cancer data clustering.
• Achieved enhanced discriminative ability in extracted multi-omics fusion features.
• Successfully identified clinically significant cancer subgroups across various cancer types.

Conclusions:

• The proposed CACL framework offers a powerful approach for multi-omics data integration in cancer research.
• CACL significantly improves cancer subtype classification and aids in the discovery of novel, clinically relevant subgroups.
• This method holds promise for advancing personalized cancer therapy through more precise subtyping.